Professor Meir Pugatch Portuguese Interview: Brazil will have economic and social benefits to the development of biotechnology

Expert at the University of Haifa (Israel) has presented on Tuesday (29/April/2014), a recent study on the biotechnology market in eight countries: Full article in Portuguese

New Report on the Value of Cross-Border Data

Pugatch Consilium has launched a new report, At the Cutting Edge, on the benefits of cross-border data to consumers, companies and governments. The report considers the value and applications of cross-border data in different countries around the world today. It analyzes a wide range of personal, social and economic benefits using case studies and anecdotes as well as statistical analysis. The report also presents a set of enabling and deterrent factors of these flows. Download a copy from the Research & Analysis Reports page.

Intellectual Property: Bristol-Myers Squibb and the Medicines Patent Pool – An Unlikely Marriage?

The Role of the Medicines Patent Pool in Stimulating the Development and Availability of Global Health Medicines. Full article at the Lexxion Website

On Intellectual Property, A New Strategy

India could use IP rights to take its rightful place as a leader in global innovation. Read the full article written by Professor Meir Pugatch at The Indian Express

When National Champions Fall

The case of Teva requires us to revise our thinking about national champions and national interests;
Prof. Meir Perez Pugatch addresses the current situation with Teva pharmaceuticals – the biggest generics company in the world – in Israel and how it has been impacted by the patent expiration of Copaxon. Full article at Pharmaphorum Media

Professor Meir Pugatch at the Montréal InVivo/LSO – Breakfast round-table IP protection – Ottawa

Prof. Meir Pugatch presenting at the Montréal InVivo/LSO – Breakfast round-table IP protection in Ottawa

Full video at: http://www.youtube.com/watch?v=IkmC5DQ5b88&feature=youtu.be

Innovative Drug Research & Development in Russia Conference

Prof. Pugatch will be moderating the regulatory panel on: Government support, strategies and policies for promoting R&D, at the 4th Annual “Innovative Drug Research & Development in Russia” Conference, 19 November 2013

Rule of Law

Pugatch Consilium and the Coalition for the Rule of Law in Global Markets Introduce the Global Business Rule of Law Dashboard at the AACCLA’s 46th Annual Meeting -Forecast on Latin America and the Caribbean” Conference, 30 September 2013 View the Presentation

More Voices Enter Clinical Trials Data Sharing Debate in Europe

Pugatch Consilium’s paper released last week, receives an overview by PhRMA!  Read more at: http://phrma.org/catalyst/more-voices-clinical-trials-data-sharing-debate-europe

Pugatch Consilium Launches New Paper on Clinical Trials

Pugatch Consilium launches new paper on Clinical trials and data transparency examining the public interest case for more pro-active release of clinical trials data and asking whether the benefits to public welfare are outweighed by the hurdles of bureaucracy, patient privacy and concerns over protection of IPRs and commercial confidentiality. Download a copy from the Research & Analysis Reports page.

Prof. Pugatch at the High Level Panel of EFPIA 2013 Annual Meeting

Watch the comments made by Prof. Pugatch at the high level panel of EFPIA 2013 Annual meeting

http://www.youtube.com/watch?v=Z-I4Y2A3c24

Prof. Pugatch keynote speech on the “Five megatrends in the pharmaceutical industry and its implications for emerging markets”

Prof. Pugatch keynote speech on the “five megatrends in the pharmaceutical industry and its implications for emerging markets”, at the 19th Annual International Russian Pharmaceutical Forum, St. Petersburg, 21-23 May 2013 http://www.adamsmithconferences.com/en/event/pharma-industry-russia

Pugatch Consilium at BIO 2013 Chicago

Dr David Torstensson, Senior Consultant with Pugatch Consilium, is attending the 2013 BIO International Convention in Chicago, USA.

Does the Indian Supreme Court’s decision on Glivec make April Fools of us all?

In a recent blog published on PharmaExec.com, we examine the consequences for innovation of the recent decision by India’s Supreme Court regarding a patent for Glivec: Read More 

Are software patents ‘a bit of a mess’?

In 1968, Martin Goetz was awarded the first patent on his code solution for sorting data. As smartphone wars are inclining and many patent infringements are being filed in the US, Martin thinks that the field is now “a big mess” and hopes that “it will get straightened out in time”.

As patent-frenzy goes out of control, are patent examiners overwhelmed to a point inventions aren’t checked thoroughly? Read more at the Guardian

Coverage of GIPC-Pugatch Consilium International IP Index

Reuters has published coverage of the US Chamber of Commerce’s Global Intellectual Property Center and the Pugatch Consilium’s new international, cross-sectoral intellectual property index, which was released today in Washington DC. The first edition of the GIPC Index scored 11 countries based on 25 indicators, with the US and UK ranking at the top and India and China at the bottom.

Professor Meir Pugatch speaking at WIPO/UNECE event

Professor Meir Pugatch will speak at an inter-regional seminar on the economic issues of intellectual property rights organized by a partnership of the World Intellectual Property Organization, the United Nations Economic Commission for Europe and the Israel Patent Office. The event will take place September 11-12, 2012 in Jerusalem. Prof. Pugatch will discuss the economics of IPRs in the 21st century and whether there is need for a paradigm shift in IP policy, with a special focus on the case of Israel.

The Swiss on top – Global Innovation Index 2012

Last week INSEAD Business School released the 2012 Global Innovation Index (GII), a ranking of 141 countries ability to innovate and actual innovation outputs. In terms of the rankings there are relatively few surprises; the Scandinavian countries, Switzerland, Singapore and Hong Kong all round out the top-10. Perhaps a bit more ominously the United States continues its relative slide, dropping to 10^th from 7^th last year. Read more about the country rankings and access the GII here

Pugatch Consilium Coverage in Nature

Pugatch Consilium’s recent report, Taking Stock: the Gains of Global Biotechnology Research from IPRs, which examines the relationship between IPRs, biotechnology research and economic growth in emerging markets (released at the BIO convention yesterday) was covered extensively in an online posting by Nature Magazine.
To access the article please click here

BIO-Pugatch Consilium Report on IPRs Launched at BIO 2012

Today Pugatch Consilium releases a new report comissioned by BIO at the BIO 2012 convention in Boston. The title of the report is Taking Stock: How Global Biotechnology Benefits from Intellectual Property Rights. To access the report please click here